API Gallery
Sodium Valproate API market is experiencing a CAGR of 5.8% during the forecast period, driven by the increasing prevalence of neurological disorders such as epilepsy, bipolar disorder, and migraine.
Solifenacin Succinate API market is experiencing a CAGR of 50.9% during the forecast period.
Solriamfetol hydrochloride market is experiencing a CAGR of 6.5% during the forecast period.
Somatostatin market is experiencing a CAGR of 7.1% during the forecast period.
Sorbitol API market is experiencing a CAGR of 6.4% during the forecast period. The market growth is driven by the increasing demand for sugar substitutes and low-calorie sweeteners in food & beverage products, pharmaceuticals, and cosmetics.
Sotalol Hydrochloride market is experiencing a CAGR of 8.8% during the forecast period.
Sotorasib market is experiencing a CAGR of 7.2% during the forecast period.
Strontium citrate market is experiencing a CAGR of 7.4% during the forecast period.
The Oxaliplatin market is projected to grow at a CAGR of 5.6% from 2025 to 2035, driven by the rising global burden of colorectal cancer, increasing adoption of combination chemotherapy regimens, and the growing availability of generic formulations.
The Bismuth Subsalicylate API market is projected to grow at a CAGR of 7.2% during the forecast period 2025-2035. This growth is primarily driven by its increased use in gastrointestinal treatments, anti-diarrheal medications, and veterinary healthcare. Bismuth Subsalicylate is a key active pharmaceutical ingredient in over-the-counter (OTC) medications for treating digestive issues, including indigestion, nausea, and diarrhea.
Stiripentol market is experiencing a CAGR of 6.2% during the forecast period.
Streptococcus Faecalis market is experiencing a CAGR of 7.2% during the forecast period, Growth is driven by increasing demand for probiotic-based treatments, particularly for gastrointestinal disorders, antibiotic-associated diarrhea, and irritable bowel syndrome (IBS).
Succinylcholine chloride market is experiencing a CAGR of 6.1% during the forecast period, driven by rising surgical procedures, expanding anesthesia applications, and increasing demand from emerging economies.
Sucralfate market is experiencing a CAGR of 6.2% during the forecast period. The market growth is primarily driven by the rising prevalence of gastric ulcers, GERD, and peptic ulcer diseases.
Search from 10,000 + API reports
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
